WallStSmart

Balchem Corporation (BCPC)vsEcolab Inc (ECL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ecolab Inc generates 1451% more annual revenue ($16.84B vs $1.09B). BCPC leads profitability with a 15.1% profit margin vs 12.6%. ECL appears more attractively valued with a PEG of 2.95. BCPC earns a higher WallStSmart Score of 58/100 (C).

BCPC

Buy

58

out of 100

Grade: C

Growth: 6.0Profit: 7.5Value: 2.7Quality: 9.0
Piotroski: 7/9Altman Z: 3.74

ECL

Buy

53

out of 100

Grade: C-

Growth: 4.7Profit: 7.0Value: 3.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BCPCSignificantly Overvalued (-38.1%)

Margin of Safety

-38.1%

Fair Value

$129.34

Current Price

$164.39

$35.05 premium

UndervaluedFair: $129.34Overvalued

Intrinsic value data unavailable for ECL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BCPC3 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.7410/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

Operating MarginProfitability
20.8%8/10

Strong operational efficiency at 20.8%

ECL2 strengths · Avg: 9.0/10
Market CapQuality
$80.38B9/10

Large-cap with strong market position

Return on EquityProfitability
21.1%9/10

Every $100 of equity generates 21 in profit

Areas to Watch

BCPC2 concerns · Avg: 3.0/10
P/E RatioValuation
33.6x4/10

Premium valuation, high expectations priced in

PEG RatioValuation
3.322/10

Expensive relative to growth rate

ECL4 concerns · Avg: 3.5/10
P/E RatioValuation
38.3x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
3.3%4/10

3.3% earnings growth

Debt/EquityHealth
1.373/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : BCPC

The strongest argument for BCPC centers on Altman Z-Score, Debt/Equity, Operating Margin. Profitability is solid with margins at 15.1% and operating margin at 20.8%. Revenue growth of 11.2% demonstrates continued momentum.

Bull Case : ECL

The strongest argument for ECL centers on Market Cap, Return on Equity.

Bear Case : BCPC

The primary concerns for BCPC are P/E Ratio, PEG Ratio.

Bear Case : ECL

The primary concerns for ECL are P/E Ratio, EPS Growth, Debt/Equity.

Key Dynamics to Monitor

BCPC profiles as a mature stock while ECL is a value play — different risk/reward profiles.

ECL carries more volatility with a beta of 0.89 — expect wider price swings.

BCPC is growing revenue faster at 11.2% — sustainability is the question.

ECL generates stronger free cash flow (489M), providing more financial flexibility.

Bottom Line

BCPC scores higher overall (58/100 vs 53/100), backed by strong 15.1% margins and 11.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Balchem Corporation

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Balchem Corporation develops, manufactures, and markets specialty ingredients and performance products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. The company is headquartered in New Hampton, New York.

Ecolab Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Ecolab Inc., headquartered in St. Paul, Minnesota, is an American corporation that develops and offers services, technology and systems that specialize in water treatment, purification, cleaning and hygiene in a wide variety of applications. It helps organizations both private market as well as public treat their water, not only for drinking directly, but also for use in food, healthcare, hospitality related safety and industry.

Want to dig deeper into these stocks?